You Searched For: Microcarriers

Upstream processing for vaccines Optimal production of vaccines is achieved in mammalian expression and insect systems using cell lines that are anchorage-dependent or suspension enabled. For most vaccines optimal production is achieved in mammali...

细胞疗法的上游流程 与其他生物制剂相关的生产量（例如，单克隆抗体：2000L至10000L）相比，细胞疗法的生产量通常在1L至10L之间。 即使质量参数也不同 细胞疗法不是争取最大的效价和蛋白质量，而是着眼于最大的细胞给药剂量和所施用的细胞/组织的功能。 因此，培养基，补充剂，生物反应器系统和起始细胞质量等上游生产参数非常重要。 最后，在完成培养过程后，需要使用不影响细胞产品质量的细胞解离试剂收获治疗细胞。 探索细胞疗法上游流程的解决方案 Avantor Seradigm血清 Cell c...

Upstream Vaccine Production Technologies & Solutions in Bioprocessing Optimal production of vaccines is achieved in mammalian expression and insect systems using cell lines that are anchorage-dependent or suspension enabled. For most vaccines opti...

Upstream processing for vaccines Optimal production of vaccines is achieved in mammalian expression and insect systems using cell lines that are anchorage-dependent or suspension enabled. For most vaccines optimal production is achieved in mammali...

Upstream processing for vaccines Optimal production of vaccines is achieved in mammalian expression and insect systems using cell lines that are anchorage-dependent or suspension enabled. For most vaccines optimal production is achieved in mammali...

Upstream processing for cell therapy 他の生物製剤に関連する生産量（例：mAb：2000L〜10000L）と比較して、細胞療法の生産量はより一般的に1L〜10Lです。 品質パラメータも異なります。 細胞療法は、最大の力価とタンパク質の品質を追求する代わりに、送達のための最大の細胞用量と、投与される細胞/組織の機能に焦点を合わせています。 したがって、培地、サプリメント、バイオリアクターシステム、および開始細胞の品質をカバーする上流の生産パラメーターは非常...

細胞培養 自家細胞と同種異系細胞の両方が、アフェレーシス、吸引物、および外科的生検を含むがこれらに限定されない方法を利用するドナーから得られる。 目的のドナー細胞は、望ましくない汚染物質を除去するために処理され、細胞培養手順のために準備されます。 最終的な細胞産物に必要な数を増やすために、ドナー細胞は、サイトカイン、成長因子、および必須アミノ酸とビタミンを補充した培地で培養されます。 付着依存性ドナー細胞用に設計されたバイオリアクターシステムも使用されます。 多くのドナー細胞は、動物の血清...

Upstream processing for vaccines Optimal production of vaccines is achieved in mammalian expression and insect systems using cell lines that are anchorage-dependent or suspension enabled. For most vaccines optimal production is achieved in mammali...

Upstream processing for vaccines Optimal production of vaccines is achieved in mammalian expression and insect systems using cell lines that are anchorage-dependent or suspension enabled. For most vaccines optimal production is achieved in mammali...

Upstream Vaccine Production Technologies & Solutions in Bioprocessing Optimal production of vaccines is achieved in mammalian expression and insect systems using cell lines that are anchorage-dependent or suspension enabled. For most vaccines opti...

Upstream processing for vaccines Optimal production of vaccines is achieved in mammalian expression and insect systems using cell lines that are anchorage-dependent or suspension enabled. For most vaccines optimal production is achieved in mammali...

Upstream processing for vaccines Optimal production of vaccines is achieved in mammalian expression and insect systems using cell lines that are anchorage-dependent or suspension enabled. For most vaccines, optimal production is achieved in mammal...

Cell culture Both autologous and allogeneic cells are obtained from donors utilizing methods including but not limited to apheresis aspirates and surgical biopsies. The donor cells of interest are processed to remove undesirable contaminants and p...

Upstream processing for vaccines Optimal production of vaccines is achieved in mammalian expression and insect systems using cell lines that are anchorage-dependent or suspension enabled. For most vaccines optimal production is achieved in mammali...

Upstream processing for vaccines Optimal production of vaccines is achieved in mammalian expression and insect systems using cell lines that are anchorage-dependent or suspension enabled. For most vaccines optimal production is achieved in mammali...

Upstream processing for vaccines Optimal production of vaccines is achieved in mammalian expression and insect systems using cell lines that are anchorage-dependent or suspension enabled. For most vaccines optimal production is achieved in mammali...